FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 84693 - Secretary's Advisory Committee on Long Covid - Agency Authority

GENERAL INFORMATION

Committee Name	Secretary's Advisory Committee on Long Covid	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	84693
Original Establishment Date	11/6/2023	Committee Status	Terminated
Actual Termination Date	2/19/2025	Committee URL	https://www.hhs.gov/ash/advisory-committees/lon...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	20
Terminated This FY	Yes	Designated Fed Officer Position Title*	Director, Office of Long COVID Research and Practice
Merged This FY		Designated Federal Officer Prefix	Dr.
Current Charter Date	11/6/2023	Designated Federal Officer First Name*	Ian
Date Of Renewal Charter	11/6/2025	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Simon
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	771-216-7754
Establishment Authority*	Agency Authority	Designated Federal Officer Fax*	202-2052107
Specific Establishment Authority*	42 U.S.C. 217a, Section 222	Designated Federal Officer Email*	ian.simon@hhs.gov
Effective Date Of Authority*	11/6/2023
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	National Policy Issue Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	No
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Committee will bring perspectives from outside the government to help inform action of the Executive Branch on Long COVID and associated chronic conditions. The functions of the Committee are solely advisory in nature
How is membership balanced?*	The Committee will be comprised of voting public members, non-voting industry representatives, and non-voting ex officio federal liaisons a. Voting public members will draw from the following areas of expertise i. Long COVID and related groups: Representation from individuals living with infection-association chronic conditions and organizations directly engaged in supporting people living with Long COVID. ii. Professional Associations: Representation from medical professional, behavioral health and human services associations representing practitioners caring for people with Long COVID, including those representing the primary healthcare system. iii. Disability and Chronic Illness Groups: Representation from associations, researchers, or organizations focused on disability and chronic illness, and their possible interplay with Long COVID. iv. Public Health and related groups: Representation from public health groups supporting communities in addressing the impacts of Long COVID and associated chronic conditions. v. Healthcare and Social Care Providers: Clinical care settings and health systems involved in providing care for patients with Long COVID, including in underserved areas, such as rural communities. vi. Employee and Employer Related Groups: Representation from employee and employer experts, attorneys, or organizations involved in addressing the impacts of Long COVID in the workplace, including discrimination. vii. Research: Researchers and research institutions involved in Long COVID and associated chronic conditions research. b. Non-voting Industry Representatives may include those involved in, or representing those involved in, Long COVID research and development, including prevention, diagnostics, and treatment. c. Non-voting Federal Liaisons engaged in or supporting Long COVID work may be solicited as ex officio members. To the extent possible, composition of the Committee will reflect the experience of a cross-section of persons with Long COVID and multidisciplinary expertise of those supporting and caring for those affected as well as specific clinical, medical, public health, behavioral health, human services, employment, data science, and research expertise.
How frequent & relevant are cmte mtgs?*	Up to three meetings of the Committee per year are expected. Meetings of the full Committee will be held at the call of the Chair (with the DFO’s approval) or upon request of the Assistant Secretary for Health or Secretary. Meetings will be announced and open to the public except as determined otherwise by the Secretary or other official to whom authority has been delegated, in accordance with 5 U.S.C. 552b(c).
Why advice can't be obtained elsewhere?*	There is not another federal advisory committee or mechanism for obtaining external recommendations on infection-associated chronic conditions, including Long COVID.
Why close or partially close meetings?	N/A
Recommendation Remarks	N/A

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	Yes
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	N/A
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	N/A	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	Committee has not yet started	Grants Review Comment	N/A
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Committee has not yet started	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	No
% of Recs Fully Implemented Comment	Committee has not yet started	Access GSA FACA Website	No
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Committee has not yet started	Access Other	No
Agency Feedback*	Not Applicable	Access Comment	N/A
Agency Feedback Comment*	Committee has not yet started	Narrative Description*	Committee has not yet started

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:11 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Public Health

Custom Links

Committee Level Reports